Location: Digital event via Zoom Conference Call.

Virtual event where participants will explore innovative approaches to running both NHS and private hospitals, with two of the best run clinically-led hospitals - University Hospitals Birmingham and the Cleveland Clinic.

We will be flipping the script during this roundtable by exploring how clinician-led organisations can use data and information to best look after patients and communities.

Dr James Gutierrez, Chief of Quality, Safety and Patient Experience at the Cleveland Clinic will give us insight into how the American health giant uses clinical information. He’ll be joined by Dr David Rosser, CEO of University Hospitals Birmingham NHS Foundation Trust, to discuss how clinical information is best used in the NHS. There will then be the opportunity for open debate during a roundtable.

Dr James Gutierrez

Dr James Gutierrez is a doctor of Internal Medicine and has been with Cleveland Clinic for over 20 years. In his current role, he is responsible for governance and regulatory compliance, as well as for developing the Quality, Patient Safety, and Patient Experience programmes for Cleveland Clinic London, which will open its doors in early 2022.

Prior to moving to London in the fall of 2018, Dr. Gutierrez served as the Chair of the Department of Community Internal Medicine, as well as the President and Medical Director for the Cleveland Clinic Medicare ACO. He also served a five-year term on Cleveland Clinic’s Board of Governors / Medical Executive Committee.

Dr. Gutierrez received his BA in Biochemistry (1986), as well as his MD degree (1990), from Case Western Reserve University in Cleveland, Ohio. He completed his residency in Internal Medicine, followed by a Chief Residency year, at Yale-New Haven Hospital in New Haven, CT.

His interests include quality and safety in health care, patient experience and engagement, and physician leadership development.

Dr David Rosser

David qualified from University College of Medicine, Cardiff in 1987, worked in general medicine and anaesthesia in South Wales, moving to London in 1993 as a research fellow in critical care and subsequently Lecturer in Clinical Pharmacology in UCLH. He was appointed to a Consultant post in Critical Care at University Hospitals Birmingham in 1996.

In 1998 he was appointed as Specialty Lead for Critical Care; as Group Director responsible for Critical Care, Theatres, CSSD and Anaesthesia in 1999; and as Divisional Director responsible for ten clinical services in 2002.

David was seconded two days per week to the NPfIT in 2004 and appointed as Senior Responsible Owner for e-prescribing in November 2005-April 2007.

In December 2006, David was appointed as Executive Medical Director of UHB, with responsibilities including Executive Lead for Information Technology. He has led the in-house development and implementation of advanced decision support systems into clinical practice across the organisation.

He took up the role of Deputy Chief Executive with responsibility for clinical quality at Heart of England NHS Foundation Trust (HEFT) in November 2015, in addition to the Medical Director role at UHB, and was appointed as Executive Medical Director of HEFT in March 2016. When the two trusts merged in April 2018, David continued in his role as Executive Medical Director and also became the Deputy Chief Executive for the combined Trust.

David was appointed as Chief Executive of UHB on 1 September 2018.